tiprankstipranks
Trending News
More News >
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market
Advertisement

X4 Pharmaceuticals (XFOR) Income Statement

Compare
1,080 Followers

X4 Pharmaceuticals Income Statement

Last quarter (Q2 2025), X4 Pharmaceuticals's total revenue was $1.97M, an increase of 250.44% from the same quarter last year. In Q2, X4 Pharmaceuticals's net income was $-25.74M. See X4 Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.56M$ 0.00$ 0.00$ 0.00$ 3.00M
Gross Profit
$ 1.76M$ -2.00M$ -1.99M$ -1.89M$ 3.00M
Operating Expenses
$ 38.16M$ 107.52M$ 87.57M$ 85.11M$ 62.87M
Depreciation and Amortization
$ 796.00K$ 419.00K$ 1.99M$ 499.00K$ 1.23M
EBITDA
$ -27.58M$ -107.10M$ -87.57M$ -84.54M$ -58.06M
Operating Income
$ -36.40M$ -107.52M$ -87.57M$ -85.11M$ -59.87M
Other Income/Expenses
$ -739.00K$ 6.43M$ -6.27M$ -3.57M$ -2.11M
Pretax Income
$ -37.14M$ -101.09M$ -93.84M$ -88.68M$ -61.98M
Net Income
$ -37.45M$ -101.17M$ -93.87M$ -88.70M$ -62.13M
Per Share Metrics
Basic EPS
$ -5.70$ -17.10$ -45.60$ -119.70$ -92.70
Diluted EPS
$ -5.70$ -17.10$ -45.60$ -119.70$ -92.70
Weighted Average Shares Outstanding
-----
Weighted Average Shares Outstanding (Diluted)
-----
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis